This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis of the clinical study was conducted on the basis of treatment completers only. The primary health outcomes used in the analysis were graft survival, incidence of hepatic artery thrombosis, re-transplantation within 30 days after transplantation and allograft rejection. The children in the intervention group were younger (3.8 +/-4.8 years) than those in the control group (6.9 +/-6.3 years), (p=0.01). There was a lower proportion of girls in the intervention group, 43.4% versus 64.9%, (p=0.0002). The two groups did not receive the same primary immunosuppression. Children in the control group received OKT3, cyclosporine, azathioprine and corticosteroids, while those in the intervention group received tacrolimus plus corticosteroids. The authors did not adjust for confounding factors in the clinical outcomes.
Effectiveness results
Allograft rejections were lower in the intervention group (28%) than in the control group (47%), (p=0.06).
A greater proportion of patients in the intervention group had hepatic artery thrombosis, 8.5% versus 2.8%, (p=0.28). However, the difference was not statistically significant.
There were no statistical differences in the graft survival between the intervention (86%) and control (78%) groups, (p=0.23). There was also no statistical difference in the re-transplantation incidence, 2.1% (intervention) versus 0% (control), (p=0.41).
Clinical conclusions
The transition to home programme in children who underwent OLT did not compromise either the safety or clinical outcomes.
Measure of benefits used in the economic analysis
The authors did not develop a summary benefit measure. A cost-consequences analysis was performed.
Direct costs
The direct costs were for organ retrieval, surgery and hospitalisation for OLT. The total cost of hospitalisation included the inpatient costs and the costs of the transition to home programme (outpatient visits, outpatient pharmacy, outpatient laboratory and home care). The surgical costs and organ retrieval costs were identified by specific charge codes. The costs of outpatient physician visits were determined from current protocol terminology codes. The costs for home care were estimated from a sub-group of 15 children who received all of their home care services through the authors' institution. All of the costs were adjusted for inflation. The duration of follow-up was 3 months. The transition to home period was defined as the 7 days after discharge from the hospital following the OLT admission. Discounting was unnecessary. The costs and the quantities were not reported separately. The price year was not stated.
Statistical analysis of costs
Statistical analyses of the costs were performed using Fisher's exact test or Student's t-test. The authors presented mean values and standard deviations. Multivariate analyses were carried out to identify potential predictive factors of the costs and length of hospitalisation.
